3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting researcher focus due to initial information suggesting different pharmacological properties. Present analyses suggest that 3-HPC may exhibit independent responses on the nervous structure, arguably influencing to some of the unanticipated manifest